phase iii trial of rusfertide in patients with polycythemia vera
Published 2 years ago • 440 plays • Length 2:08Download video MP4
Download video MP3
Similar videos
-
1:30
the verify trial: rusfertide in patients with polycythemia vera
-
1:56
rationale for verify: rusfertide added to ongoing therapy in patients with polycythemia vera
-
5:42
an update on revive: rusfertide in patients with polycythemia vera
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
3:10
promising trials in polycythemia vera
-
1:12
contemporary challenges in polycythemia vera management
-
16:13
3mensio ct pre-case planning: valve-in-valve tavr in trifecta
-
12:49
3mensio ct pre-case planning: valve-in-valve tavr in homograft
-
6:01
common signs and symptoms of polycythemia vera
-
2:16
determining when to switch from hydroxyurea to interferon-based therapy in patients with pv
-
1:34
are thrombotic risk and progression in et predictable?
-
2:02
phase ii animate trial investigating pet response-adapted treatment using nivolumab in r/r chl
-
2:55
pv-aim: using machine learning to predict resistance to hydroxyurea therapy in patients with pv
-
1:39
upcoming agents in et and pv
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
3:59
pv: outcomes, unmet needs, and therapeutic strategies
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
2:14
risk-adapted treatment of et & pv
-
1:25
the need for disease-modifying agents in pv to prevent disease progression
-
1:52
cytoreductive therapy for patients with pv
-
1:51
results for trial of lcl161 for pmf, post-pv mf, and post-et mf patients
-
1:59
mpd-rc 112 trial of pegylated interferon alpha-2a for polycythemia vera & essential thrombocythemia